Advocate for our Industry

Priority Legislation — U.S. House & Senate

NCIA supports legislation, including the bills listed below, that would align federal marijuana policies with the successful programs regulating cannabis in the majority of U.S. states.

NCIA-Lobby-Days,-May-2017-1460

INDUSTRY/BUSINESS

Secure and Fair Enforcement (SAFE) Banking Act (S. 1200 & H.R. 1595)

Provides a “safe harbor” and additional protections for depository institutions who provide a “financial product or service” to a covered business.

Lead Sponsors:
Rep. Ed Perlmutter (D-CO)
Sen. Jeff Merkley (D-OR)

Position:
Support

PROTECTING STATES

H.R. 3884 & S. 2227 Marijuana Opportunity Reinvestment and Expungement Act of 2019 or the MORE Act of 2019

To remove marijuana from the list of scheduled substances under the Controlled Substances Act and eliminate criminal penalties for an individual who manufactures, distributes, or possesses marijuana; also addresses expungements, resentencing, tax structure, among other provisions.

Lead Sponsors:Rep. Jerry Nadler (D-NY),
Sen. Kamala Harris (D-CA)

Position:
Support

INDUSTRY/BUSINESS

Regulate Marijuana Like Alcohol Act (H.R. 420)

To provide for the regulation of marijuana products, and for other purposes.

Lead Sponsor:
Rep. Blumenauer, Earl [D-OR-3]

Position:
Support

INDUSTRY/BUSINESS

Small Business Tax Equity Act of 2019 (S. 422 & H.R. 1118)

Amends the Internal Revenue Code to exempt a trade or business that conducts marijuana sales in compliance with state law from the prohibition against allowing business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.

Lead Sponsors:
Rep. Earl Blumenauer (D-OR)
Sen. Ron Wyden (D-OR)

Position:
Support

STATES' RIGHTS

Strengthening the Tenth Amendment Through Entrusting States (STATES) Act (S. 1028 & H.R. 2093)

This bill amends the Controlled Substances Act so that its provisions no longer apply to any person acting in compliance with State or tribal laws relating to the manufacture, production, possession, distribution, dispensation, administration, or delivery of cannabis. States that compliant financial transactions are not trafficking and do not result in proceeds of an unlawful transaction.

Lead Sponsors:
Rep. David Joyce (R-OH)
Sen. Cory Gardner (R-CO)
Sen. Elizabeth Warren (D-MA)

Position:
Support

STATES' RIGHTS

Ending Federal Marijuana Prohibition Act (H.R. 2012)

To amend the Controlled Substances Act to provide that Federal law shall not preempt State law.

Lead Sponsor:
Rep. Diana DeGette (D-CO-1)
Sen. Jeff Merkley (D-OR)

Position:
Support

TAX & REGULATE

Responsibly Addressing the Marijuana Policy Gap Act of 2017 (RAMP Act) (S. 421 & H.R. 1824)

Amends the Controlled Substances Act to reduce the gap between federal and state marijuana policy, and for other purposes.

Lead Sponsors:
Rep. Earl Blumenauer (D-OR)
Sen. Ron Wyden (D-OR)

Position:
Support

TAX & REGULATE

Marijuana Justice Act of 2019 (S. 597 & H.R. 1456)

To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marijuana, and for other purposes.

Lead Sponsors:
Rep. Barbara Lee (D-CA)
Sen. Cory Booker (D-NJ)

Position:
Support

TAX & REGULATE

Marijuana Revenue and Regulation Act (S. 420 & H.R. 1120)

Amends the Internal Revenue Code of 1986 to provide for the taxation and regulation of marijuana products, and for other purposes.

Lead Sponsors:
Rep. Earl Blumenauer (D-OR)
Sen. Ron Wyden (D-OR)

Position:
Support

MEDICAL

Veterans Medical Marijuana Safe Harbor Act (S. 4457 & H.R. 1151)

To allow veterans to use, possess, or transport or discuss medical marijuana with a VA physician.

Lead Sponsor:
Sen. Brian Schatz (D-HI)

Position:
Support

MEDICAL

VA Medicinal Cannabis Research Act of 2019 (S. 179 & H.R. 712)

To direct the Secretary of Veterans Affairs to carry out a clinical trial of the effects of certain health outcomes of adults with chronic pain and PTSD.

Lead Sponsor: Sen. Jon Tester (D-MT)

Position: Support

PROTECTING STATES

The Sensible Enforcement of Cannabis Act (H.R. 493)

To direct the Attorney General, in enforcing the provisions of the Controlled Substances Act relating to marijuana, to focus on certain enforcement priorities.

Lead Sponsors:
Rep. Luis J. Correa (D-CA-46)
Sen. Jeff Merkley (D-OR)

Position:
Support

PROTECTING STATES

Medical Cannabis Research Act of 2019 (H.R. 601)

To increase the number of manufacturers registered under the Controlled Substances Act to manufacture cannabis for legitimate research purposes, to authorize health care providers of the Department of Veterans Affairs to provide recommendations to veterans regarding participation in federally approved cannabis clinical trials, and for other purposes.

Lead Sponsor:
Rep.Matt Gaetz (R-FL-1)

Position:
Support

PROTECTING STATES

Compassionate Access, Research Expansion, and Respect States Act of 2019 (H.R. 127)

To extend the principle of federalism to State drug policy, provide access to medical marijuana, and enable research into the medicinal properties of marijuana.

Lead Sponsors:
Rep. Steve Cohen (D-TN-9)

Position:
Support

PROTECTING STATES

H.R. 1455 Restraining Excessive Federal Enforcement & Regulations of Cannabis (REFER) Act

To limit restrictions on and penalties for certain cannabis-related activities that are authorized by state or local law (i.e., state-authorized).

Lead Sponsors:
Rep. Lee, Barbara (D-CA)

Position:
Support

Related Posts

Related Posts

Advocacy

/ Education

How Will The Federal Government Regulate Cannabis? We Have a Plan.

Advocacy

/ Education

Webinar Recording: SAFE Banking – What’s Next?

Advocacy

/ Community

MORE Act Headed For Vote, SAFE Banking Still In Play

Advocacy. Education. Community.

Our industry supports tens of thousands of jobs, tens of millions in tax revenue, and billions in economic activity in the United States. NCIA is leading the unified and coordinated campaign to ensure this emerging sector is treated fairly under federal law.